Validation of the Polish Fatigue Severity Scale

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to validate the Polish-language version of the Fatigue Severity Scale (pFSS), a tool designed to assess the impact of fatigue on patients' lives, particularly those suffering from multiple sclerosis, amyotrophic lateral sclerosis, and stroke. The pFSS is a nine-item self-report questionnaire that uses a Likert scale to measure fatigue severity. The validation process includes translation by bilingual experts and pretesting on patients to ensure accuracy and reliability. By establishing a validated tool in Polish, the study seeks to improve the assessment of fatigue in Polish-speaking patients with these conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of definite multiple sclerosis or definite, laboratory-supported multiple sclerosis, or definite amyotrophic lateral sclerosis, or probable amyotrophic lateral sclerosis or probable, laboratory supported amyotrophic lateral sclerosis or ischemic stroke or - for healthy controls - lack of diseases, pharmacotherapy or habits, which could induce abnormal tiredness

Exclusion Criteria:

* Presence of cognitive deficits or behavioral disorder, which could disturb participation in the study.

Where it's running

• Jagiellonian University Medical College, Department of Neurology
  Krakow, Lesser Poland Voivodeship, Poland Recruiting
• Institute of Psychiatry and Neurology
  Warsaw, Poland Recruiting

Study contacts

• Principal investigator: Jakub M Antczak, MD — Jagiellonian University
• Study coordinator: Jakub M Antczak, MD
• Email: jakub.antczak@uj.edu.pl
• Phone: +48 12 400 25 50

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Biobank for studying ALS and Alzheimer's diseases

  This study is collecting blood, skin samples, and health information from people to see how genetics might help us understand and find treatments for ALS and Alzheimer's disease.

  Recruiting New York Stem Cell Foundation Research Institute · New York, New York · NCT06203106

• Identifying biomarkers of synaptic damage in multiple sclerosis

  This study is testing blood and spinal fluid samples from people with multiple sclerosis to see if certain markers can help us understand brain changes and how the disease progresses.

  Recruiting Neuromed IRCCS · Pozzilli, Isernia · NCT03217396

• Implanted Brain-Computer Interface to Help People with Severe Arm Impairment

  We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.

  Recruiting Neuralink Corp · Miami, Florida · NCT07929792

• Treadmill-based virtual reality walking training for MS patients

  This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.

  Recruiting Shepherd Center, Atlanta GA · Atlanta, Georgia · NCT07927439

• Paired VNS: How the Brain and Pupils Respond in Stroke Patients

  This study tests real-time physiologic responses to paired VNS in adults with chronic motor impairment after ischemic stroke to help tailor dosing.

  Recruiting MGH Institute of Health Professions · Boston, Massachusetts · NCT07922200

• Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS

  This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.

  Recruiting Cairo University · Giza, Giza Governorate · NCT07918339

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.